Your browser doesn't support javascript.
loading
SGLT2 inhibitors and diabetic retinopathy progression.
Nadelmann, Jennifer B; Miller, Charles G; McGeehan, Brendan; Yu, Yinxi; VanderBeek, Brian L.
Affiliation
  • Nadelmann JB; Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, 51 North 39Th St, Philadelphia, PA, 19104, USA.
  • Miller CG; Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, 51 North 39Th St, Philadelphia, PA, 19104, USA.
  • McGeehan B; Center for Preventive Ophthalmology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Yu Y; Center for Preventive Ophthalmology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • VanderBeek BL; Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, 51 North 39Th St, Philadelphia, PA, 19104, USA. Brian.vanderbeek@pennmedicine.upenn.edu.
Graefes Arch Clin Exp Ophthalmol ; 262(3): 753-758, 2024 Mar.
Article in En | MEDLINE | ID: mdl-37847267

Full text: 1 Database: MEDLINE Main subject: Macular Edema / Diabetes Mellitus / Diabetic Retinopathy / Sodium-Glucose Transporter 2 Inhibitors Limits: Aged / Humans Country/Region as subject: America do norte Language: En Journal: Graefes Arch Clin Exp Ophthalmol Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Macular Edema / Diabetes Mellitus / Diabetic Retinopathy / Sodium-Glucose Transporter 2 Inhibitors Limits: Aged / Humans Country/Region as subject: America do norte Language: En Journal: Graefes Arch Clin Exp Ophthalmol Year: 2024 Type: Article Affiliation country: United States